Loading
institutionsInstitution
Comprehensive Cancer Center Tübingen-Stuttgart
The CCC Tübingen-Stuttgart is where Hans-Georg Rammensee's group mapped tumour-presented HLA peptides and spawned Immatics and CureVac; its dermatology clinic is one of Europe's largest melanoma centres and its imaging centre pioneered combined PET/MRI.
Also called: CCC TübingenUniversitätsklinikum TübingenNCT SouthWest
Overview
The CCC Tübingen-Stuttgart is a German Cancer Aid Oncology Center of Excellence, DKTK partner site and, since 2023, part of the National Center for Tumor Diseases SouthWest. Hans-Georg Rammensee's immunology department mapped tumour-presented HLA peptides and spawned Immatics (TCR-based therapies) and, with Ingmar Hoerr, CureVac (mRNA), while the university's dermatology clinic is one of Europe's major melanoma centres. The Werner Siemens Imaging Center under Bernd Pichler pioneered combined PET/MRI, and the hospital runs large haematology, neuro-oncology and paediatric oncology programmes. Patients have access to peptide vaccine and TCR-T trials as well as molecular tumour boards.
Location
Tübingen, DE
Type
cancer center · Eberhard Karls Universität Tübingen
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#155 · 32 points (0 Newsweek + 0 NCI + 32 from 16 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-01.
Matched to Universitätsklinikum Tübingen, including child institutions. 604 works · 8,178 citations · 76% open access · 11% clinical trials · 2% reviews.
Oncology works per year
1072022
1162023
1382024
1342025
1092026
Most works
- Andrea Forschner41 works
- Friedegund Elke Meier38 works
- Dirk Schadendorf33 works
- Ulrike Leiter33 works
- Lukas Flatz33 works
- Wolfgang Andreas Bethge32 works
- Claudia Lengerke28 works
- Thomas Eigentler25 works
- Elisabeth Livingstone24 works
- Andreas Daniel Hartkopf22 works
Most cited
- Tumour immunology and peptide vaccines
- Melanoma
- PET/MRI and preclinical imaging
- NCT SouthWest
- Paediatric oncology
Lars Zender
Deputy Speaker; Medical Director, Internal Medicine VIII (Medical Oncology and Pulmonology)
Medical oncologyLiver cancer biologySenescence and tumour surveillance
Medical oncologist and cancer biologist at Tübingen, known for work on senescence surveillance and functional genomics in liver cancer.
Maximilian Niyazi
Speaker (Sprecher) of the CCC Tübingen-Stuttgart
Radiation oncologyNeuro-oncologyGlioblastoma
Radiation oncologist who speaks for the Comprehensive Cancer Center Tübingen-Stuttgart and directs radiation oncology at Tübingen University Hospital.
Sara Y. Brucker
Deputy Speaker; Medical Director, Department for Women's Health
Gynaecological oncologyBreast cancerGynaecological surgery
Gynaecologist who co-leads the CCC Tübingen-Stuttgart and directs women's health at Tübingen University Hospital, with research in breast and gynaecological cancers.
Similar pages
- PersonStefan Fröhling
Shares German Cancer Consortium (DKTK), Deutsches Netzwerk für Personalisierte Medizin, German Cancer Research Center (DKFZ).
- InstitutionUniversity Cancer Center Mainz (UCT Mainz) / Universitätsmedizin Mainz
Shares German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Neoantigen, Personalised neoantigen (mRNA) vaccines.
- InstitutionComprehensive Cancer Center Freiburg (CCCF)
Shares German Cancer Consortium (DKTK), Deutsches Netzwerk für Personalisierte Medizin, German Cancer Research Center (DKFZ), Acute myeloid leukaemia.
- IdeaShared splice-derived neoantigens as off-the-shelf vaccine targets
Shares Neoantigen, TCR-T cell therapy, Off-the-shelf cancer vaccines, Acute myeloid leukaemia.
- CompanyEvaxion
Shares Off-the-shelf cancer vaccines, Personalised neoantigen (mRNA) vaccines, Glioma & glioblastoma, Melanoma.
- PersonNina Bhardwaj
Shares Neoantigen, Off-the-shelf cancer vaccines, Personalised neoantigen (mRNA) vaccines.
- InstitutionTUM Klinikum rechts der Isar / CCC München
Shares PET/MRI, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ).
- CompanyCureVac
Shares Off-the-shelf cancer vaccines, Personalised neoantigen (mRNA) vaccines, Glioma & glioblastoma.
cancers
fronts
technologies
drugs
ApprovedTCR-T (MAGE-A4)
Afamitresgene autoleucel · Tecelra